Amygdaloid D1 Receptors Are Not Linked to Stimulation of Adenylate Cyclase

Synapse

Volumn 50, Issue 4, 2003, Pages 320-333

  Leonard, Sarah K ^a   Anderson, Carl M ^b   Lachowicz, Jean E ^c   Schulz, David W ^d   Kilts, Clinton D ^e   Mailman, Richard B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MCLEAN HOSPITAL   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d PFIZER INC   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenylate cyclase; Amygdala; D1 dopamine receptor; G protein coupled receptor (GPCR)

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ION; CALMODULIN; CYCLIC AMP; DOMPERIDONE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; ECOPIPAM; FENOLDOPAM; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; MAGNESIUM ION; PROPRANOLOL; ADENOSINE TRIPHOSPHATE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GUANOSINE TRIPHOSPHATE; GUANYLYLIMIDODIPHOSPHATE; SULFUR;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFACT; BASAL GANGLION; BRAIN HOMOGENATE; CAUDATE NUCLEUS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; MALE; NERVE CELL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RADIORECEPTOR ASSAY; RAT; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; ANIMAL; BINDING SITE; BRAIN LEVEL; CELL MEMBRANE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; HISTOLOGY; METABOLISM; METHODOLOGY; MICRODISSECTION; RADIOASSAY; SPRAGUE DAWLEY RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; AMYGDALA; ANIMALS; BINDING SITES; BRAIN CHEMISTRY; CALMODULIN; CAUDATE NUCLEUS; CELL MEMBRANE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FENOLDOPAM; FORSKOLIN; GUANOSINE TRIPHOSPHATE; GUANYLYL IMIDODIPHOSPHATE; ISOPROTERENOL; MALE; MICRODISSECTION; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; SULFUR ISOTOPES; TISSUE DISTRIBUTION;

EID: 0242569361     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10272     Document Type: Article

References (82)

1. Aggleton JP. 1992. The amygdala: neurobiological aspects of emotion, memory and mental dysfunction. New York: Wiley-Liss.
2. Ahlijanian MK, Cooper DM. 1987. Calmodulin may play a pivotal role in neurotransmitter-mediated inhibition and stimulation of rat cerebellar adenylate cyclase. Mol Pharmacol 32:127-132.
3. Ben Ari Y, Kelly JS. 1976. Dopamine evoked inhibition of single cells of the feline putamen and basolateral amygdala. J Physiol 256:1-21.
4. Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, Clarke WP. 1998. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 54:94-104.
5. Betty M, Harnish SW, Rhodes KJ, Cockett MI. 1998. Distribution of heterotrimeric G-protein beta and gamma subunits in the rat brain. Neuroscience 85:475-486.
6. Bishop JE, Mathis CA, Gerdes JM, Whitney JM, Eaton AM, Mailman RB. 1991. Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)-substituted benzamides: high-affinity ligands for CNS dopamine D2 receptors. J Med Chem 34:1612-1624.
7. Boyson SJ, McGonigle P, Molinoff PB. 1986. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci 6:3177-3188.
8. Brass LF, Woolkalis MJ, Manning DR. 1988. Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase. J Biol Chem 263:5348-5355. .
9. Brewster WK, Nichols DE, Riggs RM, Mottola DM, Lovenberg TW, Lewis MH, Mailman RB. 1990. Trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent highlypotent selective dopamine D1 full agonist. J Med Chem 33:1756-1764.
10. Brooker G, Harper JF, Terasaki WL, Moylan RD. 1979. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv Cyclic Nucleotide Res 10:1-33.
11. Brostrom CO, Brostrom MA, Wolff DJ. 1977. Calcium-dependent adenylate cyclase from rat cerebral cortex. Reversible activation by sodium fluoride. J Biol Chem 252:5677-5685.
12. 2+/calmodulin-stimulated enzyme expressed in discrete regions of rat-brain. J Biol Chem 269:12190-12195.
13. Ciliax BJ, Nash N, Heilman C, Sunahara R, Hartney A, Tiberi M, Rye DB, Caron MG, Niznik HB, Levey AI. 2000. Dopamine D5 receptor immunolocalization in rat and monkey brain. Synapse 37:125-145.
14. Cooper DM, Bier-Laning CM, Halford MK, Ahlijanian MK, Zahniser NR. 1986. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process. Mol Pharmacol 29:113-119.
15. Corvol JC, Studler JM, Schonn JS, Girault JA, Herve D. 2001. Galpha(olf) is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum. J Neurochem 76:1585-1588.
16. Dawson TM, Gehlert DR, McCabe RT, Barnett A, Wamsley JK. 1986. D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis. J Neurosci 6:2352-2365.
17. Dawson TM, Barone P, Sidhu A, Wamsley JK, Chase TN. 1988. The D1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand. Neuroscience 26:83-100.
18. Diop L, Gottberg E, Briere R, Grondin L, Reader TA. 1988. Distribution of dopamine D1 receptors in rat cortical areas, neostriatum, olfactory bulb and hippocampus in relation to endogenous dopamine contents. Synapse 2:395-405.
19. Dubois A, Savasta M, Curet O, Scatton B. 1986. Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors. Neuroscience 19:125-137.
20. Fallon JH, Koziell DA, Moore RY. 1978. Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J Comp Neurol 180:509-532.
21. Flaim KE, Gessner GW, Crooke ST, Sarau HM, Weinstock J. 1985. Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum. Life Sci 36:1427-1436.
22. Friedman E, Jin LQ, Cai GP, Hollon TR, Drago J, Sibley DR, Wang HY. 1997. D1-like dopaminergic activation of phosphoinositide hydrolysis is independent of D1A dopamine receptors: evidence from D1A knockout mice. Mol Pharmacol 51:6-11.
23. Garau L, Govoni S, Stefanini E, Trabucchi M, Spano PF. 1978. Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sci 23:1745-1750.
24. Glatt CE, Snyder SH. 1993. Cloning and expression of an adenylyl cyclase localized to the corpus striatum. Nature 361:536-538.
25. Gloor P. 1986. Role of the human limbic system in perception, memory, and affect: lessons from temporal lobe epilepsy. In: Doane BK, Livingston KE, editors. The limbic system: functional organization and clinical disorders. New York: Raven Press. p 159-169.
26. Gnegy M, Treisman G. 1981. Effect of calmodulin on dopamine-sensitive adenylate cyclase activity in rat striatal membranes. Mol Pharmacol 19:256-263.
27. Greengard P, Nairn AC, Girault JA, Ouimet CC, Snyder GL, Fisone G, Allen PB, Fienberg A, Nishi A. 1998. The DARPP-32/protein phosphatase-1 cascade: a model for signal integration. Brain Res Brain Res Rev 26:274-284.
28. Greenlee DV, Okada S. 1987. Calmodulin activates adenylate cyclase from rat anterior pituitary. Mol Pharmacol 32:743-748.
29. Halgren E. 1981. The amygdala contribution to emotion and memory: current studies in humans. In: Ben Ari Y, editor. The amygdaloid complex. North Holland: Elsevier Science. p 395-408.
30. Hamann SB, Ely TD, Grafton ST, Kilts CD. 1999. Amygdala activity related to enhanced memory for pleasant and aversive stimuli. Nat Neurosci 2:289-293.
31. Harrison JK, Mickevicius CK, Gnegy ME. 1988. Differential regulation by calmodulin of basal, GTP-, and dopamine-stimulated adenylate cyclase activities in bovine striatum. J Neurochem 51:345-352.
32. Heffner TG, Hartman JA, Seiden LS. 1980. A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 13:453-456.
33. Heit G, Smith ME, Halgren E. 1988. Neural encoding of individual words and faces by the human hippocampus and amygdala. Nature 333:773-775.
34. Herve D, Levi-Strauss M, Marey-Semper I, Verney C, Tassin JP, Glowinski J, Girault JA. 1993. G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase. J Neurosci 13:2237-2248.
35. Herve D, Le Moine C, Corvol JC, Belluscio L, Ledent C, Fienberg AA, Jaber M, Studler JM, Girault JA. 2001. Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J Neurosci 21:4390-4399.
36. Huang Q, Zhou D, Chase K, Gusella JF, Aronin N, DiFiglia M. 1992. Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proc Natl Acad Sci USA 89:11988-11992.
37. Hurd YL, Suzuki M, Sedvall GC. 2001. D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain. J Chem Neuroanat 22:127-137.
38. Jacobowitz DM, Palkovits M. 1974. Topographic atlas of catecholamine and acetylcholinesterase-containing neurons in the rat brain. I. Forebrain (telencephalon, diencephalon). J Comp Neurol 157:13-28.
39. Kebabian JW, Calne DB. 1979. Multiple receptors for dopamine. Nature 277:93-96.
40. Kebabian JW, Chen TC, Cote TE. 1979. Endogenous guanyl nucleotides: components of the striatum which confer dopamine-sensitivity to adenylate cyclase. Commun Psychopharmacol 3:421-428.
41. Kenakin T. 1995. Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol Sci 16:232-238.
42. Kilts CD, Anderson CM, Ely TD, Mailman RB. 1988. The biochemistry and pharmacology of mesoamygdaloid dopamine neurons. Ann NY Acad Sci 537:173-187.
43. Konig JFR, Klippel RA. 1963. The rat brain: a stereotaxic atlas of the forebrain and lower parts of the brain stem. Baltimore: Williams & Wilkins.
44. Lawler CP, Prioleau C, Lewis MM, Mak C, Jiang D, Schetz JA, Gonzalez AM, Sibley DR, Mailman RB. 1999. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology 20:612-627.
45. 1 dopamine receptors in the amygdala exhibit unique properties. Ann NY Acad Sci 985:536-539.
46. Lezcano N, Mrzljak L, Eubanks S, Levenson R, Goldman-Rakic P, Bergson C. 2000. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. Science 287:1660-1664.
47. Lidow MS, Roberts A, Zhang L, Koh PO, Lezcano N, Bergson C. 2001. Receptor crosstalk protein, calcyon, regulates affinity state of dopamine D1 receptors. Eur J Pharmacol 427:187-193.
48. Lovenberg TW, Brewster WK, Mottola DM, Lee RC, Riggs RM, Nichols DE, Lewis MH, Mailman RB. 1989. Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist. Eur J Pharmacol 166:111-113.
49. 1 dopamine and muscarinic receptors. Brain Res 556:101-107.
50. Mailman RB, Schulz DW, Kilts CD, Lewis MH, Rollema H, Wyrick S. 1986a. Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects. Psychopharmacol Bull 22:593-598.
51. 1 dopamine receptor. Adv Exp Med Biol 204:53-72.
52. 2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J Neurosci 10: 2587-2600.
53. 1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 46:959-971.
54. Matsuoka I, Suzuki Y, Defer N, Nakanishi H, Hanoune J. 1997. Differential expression of type I, II, and V adenylyl cyclase gene in the postnatal developing rat brain. J Neurochem 68:498-506.
55. McGaugh JL, Cahill L, Roozendaal B. 1996. Involvement of the amygdala in memory storage: interaction with other brain systems. Proc Natl Acad Sci USA 93:13508-13514.
56. Meador-Woodruff JH, Mansour A, Grandy DK, Damask SP, Civelli O, Watson SJ Jr. 1992. Distribution of D5 dopamine receptor mRNA in rat brain. Neurosci Lett 145:209-212.
57. 2+-inhibitable adenylyl-cyclase in dopaminergically innervated rat-brain regions. Mol Brain Res 22:236-244.
58. 2+-insensitive adenylyl cyclases in the rat-brain. Synapse 14:51-59.
59. 1A receptor-deficient mice. Synapse 39:319-322.
60. Onali P, Olianas MC, Gessa GL. 1984. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats. Eur J Pharmacol 99:127-128.
61. Palkovits M. 1973. Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res 59:449-450.
62. Palkovits M, Brownstein M. 1983. Microdissection of brain areas by the punch technique. In: Cuello AC, editor. Brain microdissection techniques. New York: John Wiley & Sons. p 1-36.
63. Rolls ET. 1984. Neurons in the cortex of the temporal lobe and in the amygdala of the monkey with responses selective for faces. Hum Neurobiol 3:209-222.
64. Roufogalis BD, Thornton M, Wade DN. 1976. Nucleotide requirement of dopamine sensitive adenylate cyclase in synaptosomal membranes from the striatum of rat brain. J Neurochem 27:1533-1535.
65. Schiess MC, Asprodini E, Shinnick-Gallagher P. 1988. The effects of dopamine on central amygdala neurons, in vitro intracellular recording. Soc Neurosci Abstr 14:932.
66. Schulz DW, Mailman RB. 1984. An improved, automated adenylate cyclase assay utilizing preparative HPLC: effects of phosphodiesterase inhibitors. J Neurochem 42:764-774.
67. Schulz DW, Wyrick SD, Mailman RB. 1984. [3H]SCH 23390 has the characteristics of a dopamine receptor ligand in the rat central nervous system. Eur J Pharmacol 106:211-212.
68. Schwindinger WF, Betz KS, Giger KE, Sabol A, Bronson SK, Robishaw JD. 2003. Loss of G protein gamma 7 alters behavior and reduces striatal alpha(olf) level and cAMP production. J Biol Chem 278:6575-6579.
69. Shapiro DA, Renock S, Arrington E, Sibley DR, Chiodo LA, Roth BL, Mailman RB. 2003. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28:1400-1411.
70. Spiegler BJ, Mishkin M. 1981. Evidence for the sequential participation of inferior temporal cortex and amygdala in the acquisition of stimulus-reward associations. Behav Brain Res 3:303-317.
71. Stoof JC, Kebabian JW. 1981. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366-368.
72. Stoof JC, Kebabian JW. 1984. Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 35:2281-2296.
73. Sunahara RK, Niznik HB, Weiner DM, Stormann TM, Brann MR, Kennedy JL, Gelernter JE, Rozmahel R, Yang YL, Israel Y. 1990. Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature 347:80-83.
74. Tassin JP, Bockaert J, Blanc G, Stinus L, Thierry AM, Lavielle S, Premont J, Glowinski J. 1978. Topographical distribution of dopaminergic innervation and dopaminergic receptors of the anterior cerebral cortex of the rat. Brain Res 154:241-251.
75. Undie AS, Friedman E. 1992. Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain. Eur J Pharmacol 226:297-302.
76. Undie AS, Weinstock J, Sarau HM, Friedman E. 1994. Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J Neurochem 62:2045-2048.
77. Ungerstedt U. 1971. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl 367:1-48.
78. Wang Q, Jolly JP, Surmeier JD, Mullah BM, Lidow MS, Bergson CM, Robishaw JD. 2001. Differential dependence of the D1 and D5 dopamine receptors on the G protein gamma 7 subunit for activation of adenylylcyclase. J Biol Chem 276:39386-39393.
79. Watson JB, Coulter PM, Margulies JE, de Lecea L, Danielson PE, Erlander MG, Sutcliffe JG. 1994. G-protein gamma 7 subunit is selectively expressed in medium-sized neurons and dendrites of the rat neostriatum. J Neurosci Res 39:108-116.
80. Whistler JL, Chuang HH, Chu P, Jan LY, von Zastrow M. 1999. Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23:737-746.
81. Wyrick SD, Mailman RB. 1985. Tritium-labeled (+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4, 5-tetrahydro-1H-3-benzazepine (SCH 23390). J Label Comp Radiopharm 22:189-195.
82. 1 receptor signaling. J Neurosci 20:RC91:1-5.